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Abstract 
The fight against tropical diseases such as malaria requires the development of innovative biosensing 
techniques. Diagnostics must be rapid and robust to ensure prompt case management and to avoid 
further transmission. The malaria biomarker hemozoin can catalyze atom transfer radical 
polymerizations (ATRP), which we exploit in a polymerization-amplified biosensing assay for hemozoin 
based on the precipitation polymerization of N-isopropyl acrylamide (NIPAAm). The reaction 
conditions are systematically investigated using synthetic hemozoin to gain fundamental 
understanding of the involved reactions and to greatly reduce the amplification time, while 
maintaining the sensitivity of the assay. The use of excess ascorbate allows oxygen to be consumed in 
situ but leads to the formation of reactive oxygen species and to the decomposition of the initiator 2-
hydroxyethyl 2-bromoisobutyrate (HEBIB). Addition of sodium dodecyl sulfate (SDS) and pyruvate 
results in better differentiation between the blank and hemozoin-containing samples. Optimized 
reaction conditions (including reagents, pH, and temperature) reduce the amplification time from 37 
± 5 min to 3 ± 0.5 min while maintaining a low limit of detection of 1.06 ng mL-1. The short amplification 
time brings the precipitation polymerization assay a step closer to a point-of-care diagnostic device for 
malaria. Future efforts will be dedicated to the isolation of hemozoin from clinical samples. 
Introduction 
In 2003, the World Health Organization Special Program for Research and Training in Tropical Diseases 
(WHO/TDR) published a list of criteria that an ideal test for infectious tropical diseases must fulfill.1, 2 
This criteria list is known as the acronym ASSURED (affordability, sensitivity, specificity, user 
friendliness, rapid and robust, equipment free and deliverable to end-user). Since then, many authors 
have emphasized the need for rapid tests to meet the needs of the developing world.2-7 To ensure that 
the patient receives treatment before leaving the medical facility, it is important that the results are 
established during the visit. Rapid tests allow for an immediate case-management and prevent the 
patient from having to return to the clinic several times. This is a very important factor in rural areas 
where remote contact is impossible and where the patient is unable to visit the test site several times 
due to lack of transportation or financial means. At the population level, immediate case management 
helps to decrease transmission.8, 9 In some cases, assay time can even outweigh sensitivity as described 
for Chlamydia trachomatis10 and for syphilis.11  
The specific detection of DNA sequences, proteins or other biomolecules in very small quantities is of 
primary diagnostic interest.12 Early and rapid detection even before symptoms appear maximizes the 
chances of recovery while reducing health costs.13 To achieve this objective, analyte amplification 
techniques are generally used. The most famous of these is the polymerase chain reaction (PCR) that 
has revolutionized biomedical sciences. Radical polymerizations have also been used for diagnostics 
because the successive addition of many monomers to a growing polymer chain in the radical chain 
reaction is an effective way to concentrate molecules at a site of biodetection, thus amplifying a 
sensing signal.14 Polymerization-based amplification techniques (PBA) refer to the use of a radical chain 
reaction to molecularly amplify the recognition of a target analyte.15, 16 In the field of malaria, Sikes et 
al. have proposed the combination of PBA in association with a paper based immunoassay.17 Free 
radical polymerization was initiated by an antibody-bound photoinitiator in the presence of a dye at 
the site where Plasmodium falciparum histidine-rich protein 2 (Pf HRP2) was identified by 
immunorecognition. After washing steps, trapped dye in the polymer revealed the presence of Pf HRP2 
at the recognition site. PBA systems show great sensitivity, although their specificity is achieved, in 
most cases, by immunorecognition.16 This allows to detect a wide variation of analytes, but 
manufacturing of sensor surfaces and reagents is complex and the need for several washing steps is 
laborious. Label-free detection can overcome these disadvantages, e.g., by using the intrinsic catalytic 
activity of the target analyte. For example, heme-containing enzymes and hemin are known for their 
ability to initiate polymerizations,18-20 and for their use as catalysts for reversible-deactivation radical 
polymerizations (also termed controlled radical polymerizations) such as atom transfer 
polymerizations (ATRP).21-27 Recently, our group showed that a biomarker of malaria, hemozoin (Fig. 1 
a), can be used to catalyze radical polymerizations.28 We exploited this phenomena to design a 
polymerization-amplified assay for the detection of hemozoin and, therefore, of malaria parasites. 
Hemoglobin can also be detected by the assay in a sensitive way.29 Hemozoin is a product of 
hemoglobin digestion by Plasmodium sp. parasites.30 The digestion of hemoglobin releases a significant 
amount of free heme that is toxic to the parasite. In order to disable the free heme, the parasite 
crystallizes it to form centrosymmetric μ-propionate dimers of heme (hemozoin).31, 32 During the life 
of the parasite, more and more hemozoin crystals are formed in the parasite's food vacuole. Hemozoin 
can be qualified as a pan-malaria biomarker since all Plasmodium sp. generate it during their 
intraerythrocytic life stages. However, its concentration varies greatly depending on the species as well 
as the life stage.33, 34 Nevertheless, hemozoin has been investigated as a malaria biomarker for 
diagnostic purposes via several physical detection techniques such as laser desorption mass 
spectrometry35, multiple-angle polarization scatter separation,36 magnetically induced dichroism,37-39 
laser-induced nanobubble formation,40 and Raman spectroscopy.41 Our polymerization-amplified 
hemozoin detection technique is a very sensitive method for detecting hemozoin concentrations down 
to 0.85 ng mL-1 at a confidence level of 95 %.28 To evaluate the performance of the technique, 
hemozoin was extracted from blood samples spiked with different amounts of cultured parasites. A 
limit of detection (LOD) of 10 infected red blood cells L-1 was achieved, demonstrating the possible 
application of this technique as a sensitive diagnostic test for malaria. However, the amplification time 
required for the assay was 37 ± 5 min excluding sample collection and processing, which is too long for 
practical application. One paramount feature of point of care diagnostics is that the analysis must be 
done rapidly, ideally within the time of the medical consultation of approximately 20 min.1, 7, 10, 11 
The motivation of the work described herein is to gain a greater understanding of the chemistry behind 
the hemozoin-catalyzed precipitation polymerization assay, and to optimize the reaction conditions to 
perform rapid and sensitive detection of hemozoin. Thus, we probed how the reagents used in the 
assay influence the outcome of the reaction. These reagents include the crosslinker N,N′-
methylenebis(acrylamide) (BA), ethanol as cosolvent, exogenous oxygen, the reducing agent 
ascorbate, the ATRP initiator 2-hydroxyethyl 2-bromoisobutyrate (HEBIB), the monomer N-Isopropyl 
acrylamide (NIPAAm), the surfactant sodium dodecyl sulfate (SDS), and the reactive oxygen scavenger 
sodium pyruvate. Moreover, the effects of temperature and pH on the reactions were investigated in 
order to reduce the amplification time. Using optimized reaction parameters, the hemozoin assay was 
able to be performed in less than 4 minutes with a sensitivity of 1.06 ng mL-1 for synthetic hemozoin. 
Experimental Section 
2-Hydroxyethyl 2-bromoisobutyrate (≥95 %, HEBIB), mineral oil (BioUltra grade), sodium phosphate 
monobasic (≥99.0 %), sodium phosphate dibasic (≥99.0 %), (+)-sodium L-ascorbate (≥99.0 %, Asc), 
sodium pyruvate (≥99.0 %, Pyr), ethanol (≥99.8 %, EtOH), sodium hydroxide (≥98.0 %) and sodium 
dodecyl sulfate (≥99.0 %, SDS) were purchased from Sigma Aldrich and used as received. N-Isopropyl 
acrylamide (97 %, NIPAAm) was purchased from Sigma Aldrich and was recrystallized twice from 
hexane. Synthetic hemozoin (sHz) was purchased from InvivoGen (San Diego, CA) and was used as 
received. Ultrapure water was made with Purelab Flex II (Veolia water system) at 18.2 mΩ using the 
purification pack LC208. UV-vis measurements were performed on an Analytik Jena Specord 50 Plus 
spectrophotometer equipped with a 6-cell changer that was thermostatted with a Julabo heating 
circulator TD-6. Semi-micro UV cuvettes (light path 10 mm, optical glass) were obtained from Hellma 
Analytics. 
In a typical experiment, NIPAAm (639 mg, 5.65 mmol) and HEBIB (22.42 µL, 32.6 mg, 296 µmol) were 
added to a volumetric flask. Sodium phosphate buffer (pH 7.0, 0.1 mM, 10 % v/v EtOH) was used to 
dissolve the reagents to a final volume of 6 mL. 850 µL of this solution was introduced into a cuvette. 
50 µL of 0.4 M sodium hydroxide solution in ultrapure water containing various hemozoin 
concentrations were added. The solution was then sealed from ambient air by overlaying it with 
mineral oil (400 µL) and incubated in the cell changer for 3 min. During this time, sodium ascorbate 
(158 mg, 0.80 mmol) was dissolved in a volumetric flask (1 mL) with sodium phosphate buffer (pH 7.0, 
0.1 mM, 10 % EtOH). Reactions were started by the addition of 100 µl sodium ascorbate solution to 
the reaction mixture, using a pipette tip to inject the solution through the oil layer. Final reagent 
concentrations were 36.3 mM HEBIB, 800 mM NIPAAm and 80 mM Asc. pH indicated in this paper 
refers to the pH of the buffer used for the preparation of solutions. For sodium phosphate buffer pH 
7.0 (0.1 mM, 10 % EtOH) the pH after mixing of all reagents was 7.07.  
For experiments with various ethanol concentrations, solutions containing water and EtOH in different 
ratios (3 mL) were added to sodium phosphate buffer (7 mL, pH 6.0, 0.1 mM). Buffers with EtOH 
concentrations 0, 1, 5, 10, 20 and 30 % v/v were made. NIPAAm (639 mg, 5.75 mmol) and HEBIB (60 
µL, 87.2 mg, 719 µmol) were dissolved in phosphate buffer containing EtOH (6 mL). 850 µL of this 
solution was introduced into a cuvette. The rest of the procedure was performed as described above. 
Degassed solutions were obtained by bubbling argon (ALPHAGAZ 1 AR, 99.999 %) for 20 min through 
the solutions under stirring. Solutions were then introduced with a syringe to the cuvette below the 
oil layer.  
For experiments using pyruvate, sodium pyruvate (604 mg, 5.49 mmol) was dissolved in sodium 
phosphate buffer (8 mL, pH 7.0, 0.1 mM, 10 % EtOH). The resulting solution was further used to 
prepare the solutions of NIPAAm, HEBIB and sodium ascorbate. 
UV-vis extinction measurements were recorded at 410 nm every 22.2 s with an integration time of 0.1 
s. (Please see Supplementary Fig. 1 that provides details for the choice of wavelength). Extinction is 
the sum of the contributions of absorbance and light scattering on the transmission of light through a 
cuvette, i.e., –log[T], where T is the transmission at a defined wavelength. The rates of turbidity 
formation 
∆𝐸
∆𝑡
 were determined using a MATLAB script (see Supplementary Information: MATLAB 
Script). The script calculates a linear regression, fitted at every two points over the entire reaction 
time. Since turbidity formation is sigmoidal over time, the inflection point corresponds to the location 
where the slope is the highest. The highest linear regression slope was, therefore, used as a measure 
of the rate of turbidity formation 
∆𝐸
∆𝑡
. The decision limit and the detection limit were calculated 
according to Hubaux and Vos.42 This method connects a linear calibration curve with the confidence 
limit. The decision limit corresponds, a priori, to the lowest signal differentiable from the non-catalyzed 
reaction. The detection limit is, a priori, the lowest signal that can not be confused with the blank. The 
maximum amplification time was defined as the time needed for the blank reaction to reach maximum 
∆𝐸
∆𝑡
. 
UV-vis spectra were measured from 350 nm to 800 nm with a  of 1 nm at a scan speed of 10 nm s-1, 
unless otherwise noted. Kinetic UV-vis spectra were followed by spectral scans between 320 to 700 
nm, at a speed of 50 nm s-1 and with 5 nm. 
Results and discussion 
General description of the hemozoin assay 
The assay discussed herein is based on the thermoresponsive properties of poly(N-
isopropylacrylamide) (PNIPAAm). When heated higher than 34 °C, PNIPAAm precipitates in aqueous 
solution while the monomer remains soluble (Fig. 1 b).43-45 The radical polymerization of NIPAAm at 
elevated temperatures, therefore, results in the precipitation of the formed chains. This changes the 
macroscopic appearance of the solution from transparent to milky due to the scattering of light by the 
suspension of PNIPAAm particles. The addition of a crosslinker to the reagent mix would create 
crosslinked PNIPAAm particles, but we found that the crosslinker BA lowered the performance of the 
assay (Supplementary Fig. 2). Therefore, crosslinkers are not used in the precipitation polymerization.  
The reaction conditions of the assay are similar to those of activators regenerated by electron transfer 
(ARGET) ATRP (Fig. 1 c). 2-Hydroxyethyl 2-bromoisobutyrate is used as an initiator. An excess of sodium 
ascorbate is employed to regenerate the catalyst and to allow the system to tolerate the presence of 
oxygen. Hemozoin, which is insoluble in physiological conditions, is dissolved in aqueous sodium 
hydroxide. Once dissolved, hemozoin is activated by sodium ascorbate which reduces the iron of 
hemozoin from the Fe(III) oxidation state to Fe(II). The reduced hemozoin can homolytically cleave the 
bromine-carbon bond of the ATRP initiator HEBIB. The transfer of bromine from the initiator to the 
catalyst forms a tertiary carbon radical which initiates radical polymerization. The catalyst can transfer 
bromine back to the growing polymer chain. However, the reaction does not proceed as typical 
reversible-deactivation radical polymerization due to the heterogeneous nature of the reaction 
mixture.28 Even though oxygen interferes with radical polymerizations, the solution is not 
deoxygenated to allow for point-of-care handling of the assay.  
 
Figure 1 Hemozoin-catalyzed precipitation polymerization of NIPAAm. a Scheme of crystal structure 
of hemozoin. b Turbidity formation during an assay catalyzed by 100 ng mL-1 of synthetic hemozoin 
(800 mM NIPAAm, 36 mM HEBIB, 80 mM Asc, 650 mM Pyr, 170 M SDS, 45 °C and pH 7.5) over time. 
c Reaction scheme of the polymerization. 
 Figure 2. Schematic representation of time-dependent extinction measurements of precipitation 
polymerizations to illustrate assay results for a catalyzed (red curve) and a non-catalyzed reaction (blue 
curve). The rate of turbidity formation (E/t) is calculated by linear regression (black dashed lines) 
over the quasi-linear increase of extinction. The amplification time (orange and green dotted lines) 
correspond to the minimal time needed to reach maximum E/t. The maximum amplification time 
(green dotted line) is the time needed for the non-catalyzed reaction to reach maximum E/t. 
 
The precipitation of PNIPAAm can be monitored by measuring the extinction of the reaction mixture 
with a UV-vis spectrophotometer at a specific wavelength (Fig. 2). As detailed in the Supporting 
Information, we chose to use 410 nm as the measuring wavelength (Supplementary Fig. 1). During the 
initial lag-phase, no turbidity formation is observed because oxygen inhibits the polymerization. The 
generated radicals as well as the excess of reducing agent overcome the inhibition of the 
polymerization by oxygen. Indeed, ascorbate oxidizes rapidly in the presence of oxygen and thus, leads 
to a rapid decrease of the dissolved oxygen concentration.46-48 After the lag phase, the polymerization 
begins and the extinction of the solution increases. The turbidity formation rate follows an almost 
linear increase, which allows the turbidity formation rate (E/t) to be determined by a linear 
regression calculated at the steepest part of the extinction curve (Fig. 2, black dashed line). We have 
previously shown that the rate of turbidity formation depends on the hemozoin concentration, making 
the test quantitative.28 The higher the concentration of dissolved hemozoin is, the faster the rate of 
turbidity formation is. However, even in the absence of a catalyst turbidity forms (Fig. 2, blue curve), 
albeit at a very slow rate and after a longer lag-phase than for hemozoin-catalyzed reactions (Fig. 2, 
red curve). Therefore, the presence of the catalyst and its concentration is assessed by the difference 
between the rate of turbidity formation of an analytical sample and a non-catalyzed background 
reaction.  
Another key parameter of our method is the amplification time, i.e. the time that the assay takes until 
it gives a quantifiable result. This is the time needed for a polymerization to reach maximum E/t. 
Because a precipitation assay with an analytical sample of unknown hemozoin concentration would 
have to be run until the non-catalyzed reaction reached maximum E/t, we define the maximum 
amplification time of the assay to be the time taken by the non-catalyzed reaction to achieve maximum 
E/t (Fig. 2, green dotted line). This is the measure with which we compare the performance of the 
assay under various reaction conditions. It should be noted that catalyzed reactions react faster than 
non-catalyzed reactions, so that they reach the highest E/t faster (Fig. 2, orange dotted line vs green 
dotted line). 
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At the end of the hemozoin-catalyzed reactions, the rate of turbidity formation decreases in the 
catalyzed reactions because the catalyst copolymerizes into the polymer.28 Heme has two vinyl groups 
that make it susceptible to radical polymerization. Precipitation of the catalyst with the polymer leads 
to the loss of catalytic activity and therefore, the rate of turbidity formation decreases. 
Cosolvent 
Dimethylformamide was used as a co-solvent in our previous publication to solubilize HEBIB in the 
assay.28 However, DMF is harmful by skin contact, causes severe eye irritation and may harm the fetus. 
In order to overcome this toxicity problem and to make the assay safer, the experiments presented 
here were performed using ethanol, which poses a smaller risk and is more accepted in the medical 
community. The optimum ethanol concentration for the assay was found to be 10 vol% because it 
resulted in the highest resolution between catalyzed and non-catalyzed reactions (Supplementary Fig. 
3).  
Presence of air 
Oxygen quenches radical polymerizations. If a polymerization is carried out in the presence of air, 
enough radicals have to be created to consume the present oxygen before the polymerization can 
start. Oxygen can therefore inhibit the polymerization and result in a lag phase at the beginning of the 
reaction and, thereby, increase the time needed for the hemozoin assay to give a meaningful result.  
One way to shorten the amplification time is to conduct the polymerization in the absence of oxygen, 
which is usually achieved by physically degassing the reaction solution, e.g. by purging the solution 
with an inert gas. However, such procedures are not feasible for an assay that is intended for use 
outside of laboratories. To reduce the effect of oxygen on the hemozoin-catalyzed polymerization, an 
excess of sodium ascorbate, a reducing agent for the Hz catalyst, was used to consume the oxygen that 
is present in the system. Moreover, an oil layer was added on top of the reaction mixture to prevent 
the diffusion of oxygen from the headspace into the solution. This technique has the advantage of 
being easy to use because no inert gas handling is required. The oxygen present at the start of the 
reaction leads to an inhibition of the polymerization causing the consumption of initiator, monomer 
and ascorbate. In addition, ascorbate oxidizes in the presence of oxygen. To assess the impact of 
oxygen consumption on reaction parameters, reagents and reaction mixtures were degassed by argon 
bubbling. Then, degassed reactions were compared to non-degassed reactions (Fig. 3).  
 
Figure 3. Influence of the presence of oxygen on the hemozoin-catalyzed precipitation polymerization. 
Reaction catalyzed by 100 ng mL-1 sHz purged with argon (black line) and non-degassed (red curve) are 
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compared to the non-catalyzed reaction purged with argon (pale green) and non-degassed (blue 
curve). Reaction conditions: 800 mM NIPAAm, 80 mM Asc, 36 mM HEBIB, 170 M SDS, 45 °C, pH 7. 
As reported in our first communication, degassing of the solutions resulted in stark improvements 
when compared to the non-degassed catalyzed reactions. The lag phase is eliminated, i.e. reactions 
started immediately after the injection of the reducing agent. Moreover, the rate of turbidity 
formation is faster. The absence of the lag phase indicates that oxygen must be first consumed before 
the polymerization can start. Moreover, excess ascorbate and initiator initially used to consume 
oxygen are now available for the catalyzed reaction resulting in faster polymerization kinetics. The 
impact of dissolved oxygen on the non-catalyzed blank reaction was not studied previously. Oxygen 
has a less pronounced effect on the non-catalyzed reaction than on the catalyzed reaction (Fig. 3), 
indicating that the formation of turbidity in the absence of catalyst is not directly dependent of oxygen. 
As a conclusion, the presence of oxygen diminishes the performance of the assay by slowing down the 
catalyzed reaction while having little effect on the blank reaction. Although degassing would be 
advantageous to improve the performance of the assay, it is not feasible for point-of-care applications. 
Deciphering the role of individual reagents 
The individual role of each reagent must be understood to identify the key parameters that can 
influence the turbidity formation rate, the amplification time and the differentiation between 
catalyzed and non-catalyzed reactions. Theoretically, in the absence of catalyst, no turbidity formation 
should occur because only the catalyst should be able to cleave the C-Br bond of the initiator and, thus, 
initiate a radical chain reaction. However, experimentally, even in the absence of a catalyst, turbidity 
is observed after some time indicating that some reagents are not stable under the reaction conditions 
and that compounds capable of initiating free radical polymerization are generated in-situ. It is 
therefore crucial to understand how the reagents and the parameters interact to affect the catalyzed 
and the non-catalyzed reactions. The initiator (HEBIB), the catalyst (Hz), and ascorbate were 
independently removed from the reaction mixture to assess their contributions to the overall reaction 
(Fig. 4). 
 
Figure 4. Contribution of individual reagents on the precipitation polymerization. Normal catalyzed 
reaction condition (pale green, 800 mM NIPAAm, 36 mM HEBIB, 80 mM Asc, 170 M SDS, 100 ng mL-
1 sHz, 45 °C, pH 7), non-catalyzed reaction (dark green), catalyzed reaction without HEBIB (purple), 
non-catalyzed reaction without HEBIB (pink), and non-catalyzed reaction without sodium ascorbate 
(black).  
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The removal of HEBIB from the catalyzed reaction reduced the rate of turbidity formation by an order 
of magnitude (Fig. 4 pale green vs purple lines).Without an initiator, the presence or absence of 
hemozoin in the reactions cannot be differentiated (Fig. 4 purple vs pink lines). In the latter case, only 
monomer and ascorbate were left in the reagent mix. However, slight precipitation was still observed. 
On the other hand, turbidity formation was completely suppressed when the reaction mixture 
consisted of initiator and monomer but no reducing agent, indicating that the monomer did not self-
polymerize and that the initiator was stable over the reaction time (Fig. 4 black line). It would therefore 
appear that sodium ascorbate initiated the polymerization and generated turbidity in solution. If 
monomer, initiator, and reducing agent were present in the reaction mixture (i.e. in a non-catalyzed 
blank reaction), the turbidity formation was twice faster than in the absence of the initiator (Fig. 4 dark 
green vs pink lines). Therefore, the turbidity observed for these non-catalyzed reactions resulted from 
an interaction between the initiator and the reducing agent that led to polymerization, as well as a 
background polymerization caused by the ascorbate itself.  
 
 
Figure 5. Contribution of ascorbate and oxygen to the non-catalyzed precipitation polymerization. 
Sodium ascorbate concentrations were investigated at 0 mM (black), 4 mM (orange), 8 mM (pale 
green), 40 mM (green) and 80 mM (pink). Reaction conditions: 800 mM NIPAAm, 0 mM HEBIB, 170 
M SDS, no sHz, 45 °C, pH 7. Please note: This noisy signal arises when PNIPAAm particles sediment, 
i.e. when larger polymer particles form. 
In order to understand the role of the reducing agent better, the ascorbate concentration was varied 
and precipitation kinetics were recorded in the presence of monomer (Fig. 5). Catalyst and initiator 
were omitted from the reaction mixtures. For all the studied concentrations, ranging from 4 mM to 80 
mM of ascorbate, polymerization was initiated. Increasing the ascorbate concentration from 4 mM to 
80 mM reduced the lag phase from 26 min to 2 min. This indicates that a higher concentration of 
ascorbate makes it possible to overcome the presence of oxygen inhibition more quickly. Moreover, 
the lowest concentrations of ascorbate resulted in the fastest rates of turbidity formation in these 
uncatalyzed reactions. Because longer amplification times and fast blank reactions are unfavorable to 
the purpose of the assay, low ascorbate concentrations should be avoided. Ascorbate concentrations 
of more than 80 mM lead to the saturation of the solution, making it difficult to solubilize the reagents. 
In order to maximize speed of the reaction, an ascorbate concentration of 80 mM was chosen for 
further experiments. 
To summarize, the non-catalyzed reaction is caused by the initiator interacting with the reducing agent 
and by the reducing agent itself. The reducing agent concentration influences the lag phase and the 
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rate of turbidity formation of the blank reaction. However, sodium ascorbate is needed in the assay to 
reduce hemozoin (which is an Fe(III) complex) and thereby create the activating catalyst species in the 
ATRP reaction. For practical reasons in this study, high doses of sodium ascorbate and initiator were 
used to help overcome the oxygen inhibition, which in return resulted in turbidity formation even in 
the absence of catalyst. Despite the complexity of the non-catalyzed reaction, it remains reproducible 
and, therefore, allows hemozoin to be detected and quantified.  
Addition of surfactant 
Surfactants are widely used to stabilize colloidal dispersions.50 The use of surfactants, such as SDS, 
shifts the LCST of PNIPAAm to a higher temperature.51 Moreover, when NIPAAm is polymerized at 
temperatures higher than its LCST in the presence of SDS, more particles of a more uniform size can 
be obtained due to the stabilization of the microgel nuclei over the nucleation and growing phases.44 
In order to observe the effect of the surfactant on the precipitation polymerization under the 
conditions of our system, SDS was added to non-catalyzed and catalyzed reactions up to a 
concentration of 34.7 mM (Fig. 6) The critical micellar concentration of SDS is approx. 8 mM at 25 °C 
in water and falls to approx. 2 mM in the presence of salts.52 Thus, it can be expected that SDS 
concentrations of 0.9 mM and lower, as used for most experiments herein, did not result in the 
formation of micelles. 
 
Figure 6. Influence of concentration of sodium dodecyl sulfate on the rate of turbidity formation for 
precipitation polymerizations catalyzed by 100 ng mL-1 sHz (red dot) and non-catalyzed reactions (blue 
triangle) (average of n = 3 and SD). The amplification time of the non-catalyzed reaction (grey square, 
average of n = 3 and SD) is displayed on the second y axis (grey square). Reaction conditions were 800 
mM NIPAAm, 36 mM HEBIB, 80 mM Asc, 45 °C and pH 7.  
Concerning the catalyzed reaction, addition of SDS increased the rate of turbidity formation strongly 
until it reached a maximum of 5.23 ms-1 at 0.170 mM SDS, most likely by increasing the number of 
formed PNIPAAm particles.51, 44 At higher concentrations, the assay read-out decreased again. This 
decrease can be attributed to a partial solubilization of precipitating PNIPAAm51 and a decrease in 
apparent activity of the catalyst either by preventing the initiator to react with the catalyst, by heme 
degradation,53, 54 or by transition of heme dimers to heme monomers.55  In order to gain insight into 
the interaction of SDS with hemozoin, UV-vis spectra of the catalyst were recorded in the presence 
and absence of SDS (Supplementary Fig. 4). SDS causes changes in the spectrum of solubilized 
hemozoin, indicating a direct interaction of the catalyst with SDS, which is in agreement with 
literature.53, 54, 56 Even though the unambiguous speciation of the hematin species that are present 
under certain conditions is beyond the context of this report, the UV-vis spectra indicate that without 
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SDS and at 0.170 mM SDS, dimers (most likely π-π dimers) of ferriprotoporphyrin IX might dominate 
while at high SDS concentrations monomers might be present.55  
For the non-catalyzed reactions, increasing the SDS concentration up to 34.7 mM raised the rate of 
turbidity formation from 0.45 to 1.57 ms-1. Moreover, the addition of SDS shortened the maximum 
amplification time from 20 ± 0.5 min (no SDS) to 7.0 ± 0.5 min (at 34.7 mM SDS).  
In conclusion, addition of SDS up to a concentration of 0.170 mM increased the differentiation 
between the catalyzed and non-catalyzed reaction by a factor of 2.5 and reduced the maximum 
amplification time to 15 min. Higher SDS concentrations would decrease the amplification time further, 
but at the cost of a loss in sensitivity.  
Use of pyruvate as a ROS scavenger 
The presence of oxygen in the assay seems to play many roles. Apart from quenching radicals, it might 
also form reactive oxygen species (ROS) with sodium ascorbate, which in turn can contribute to the 
blank reaction (Supplementary Fig. 5). Hydrogen peroxide can form by oxidation of sodium 
ascorbate.57-59 In the presence of metal traces, hydrogen peroxide degrades into reactive hydroxyl 
radicals through the Fenton reaction and can initiate polymerizations. It is also important to note that 
hydrogen peroxide is known for its capacity to degrade heme.53, 60 In the case of hemoglobin, Nagababu 
et al. showed that superoxide forms when ferrylhemoglobin (Fe(II)) is in contact with hydrogen 
peroxide, which leads to the degradation of the heme moiety. Pyruvate has been used to scavenge 
ROS because it reacts with hydrogen peroxide to form inert CO2, water, and acetate.61 In order to 
assess whether pyruvate can be used to improve the performance of the assay, the effect of pyruvate 
was investigated on catalyzed and non-catalyzed reactions at pyruvate concentrations varying from 0 
mM to the solubility limit of 650 mM (Fig. 7).  
 
Figure 7. Impact of the pyruvate concentration on the rate of turbidity formation for precipitation 
polymerizations catalyzed by 100 ng mL-1 sHz (red dot) and non-catalyzed reactions (blue triangle) 
(average of n = 3 and SD). The amplification time of the non-catalyzed reaction (grey square, average 
of n = 3 and SD) is displayed on the second y axis. Reaction conditions: 800 mM NIPAAm, 36 mM HEBIB, 
80 mM Asc, 170 M SDS, 45 °C, pH 7. 
Addition of pyruvate considerably increased the rate of turbidity formation linearly from 5.32 ms-1 to 
37.0 ms-1 for the Hz-catalyzed reactions. Concerning the non-catalyzed reactions, the rate of turbidity 
formation increased slightly with the addition of pyruvate from 0.86 ms-1 to 1.63 ms-1 while maintaining 
similar amplification times. Thus, pyruvate makes the test more efficient by increasing the 
differentiation between the catalyzed and non-catalyzed UV-vis spectra of the dissolved hemozoin 
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show significant differences in the visible Q-band region when pyruvate is added to the assay 
(Supplementary Fig. 6). Possibly, pyruvate coordinates to solubilized hemozoin and increases its 
catalytic activity. For the non-catalyzed reaction, the observed effect is not expected because the use 
of a ROS scavenger should have reduced the rate of turbidity formation by preventing the in-situ 
formation of radicals generated by ascorbate oxidation. To further investigate the role of pyruvate 
under the assay conditions, we measured the influence of pyruvate on the non-catalyzed reaction 
caused by ascorbate in the absence of initiator (Supplementary Fig. 7). The addition of pyruvate (650 
mM) reduced E/t from 0.23 ms-1 to 0.01 ms-1 while maintaining the same lag phase. The use of 
pyruvate therefore considerably reduced the turbidity resulting from the decomposition of ascorbate. 
When HEBIB was added to the system, E/t increased. Although pyruvate significantly decreases the 
contribution of ascorbate to the non-catalyzed reaction, it does not decrease the contribution of 
ascorbate together with the initiator. Buchs et al. have shown that the type and concentration of ions 
can have significant effects on the lower critical solution temperature (LCST) of PNIPAAm.62 The 
addition of sodium pyruvate at a high concentration of 650 mM might have decreased the LCST of 
PNIPAAm allowing the polymer chains to precipitate faster. Most likely, the ROS scavenging properties 
of pyruvate were offset by the change of ionic strength and ionic environment in the solution upon 
addition of pyruvate. 
In conclusion, in the presence of pyruvate, the non-catalyzed reaction is slightly faster but this effect 
is outweighed by the acceleration of the catalyzed reaction. As an outcome, pyruvate improved the 
performance of the assay by increasing the differentiation between the catalyzed and non-catalyzed 
reaction by 800 %, while not affecting the maximum amplification time. 
 
Temperature, pH, and wavelength 
Temperature, pH and measuring wavelength were investigated as key reaction parameters and data 
collection parameter to reduce the amplification time while keeping high sensitivity. The temperature 
was varied between 35 °C and 60 °C (Fig. 8).  
 
Figure 8. Influence of temperature on the rate of turbidity formation for precipitation polymerizations 
catalyzed by 100 ng mL-1 sHz (red dot) and non-catalyzed reactions (blue triangle) (average of n = 3 and 
SD). The amplification time of the non-catalyzed reaction is displayed on the second y axis (grey square, 
average of n = 3 and SD). Reaction conditions: 800 mM NIPAAm, 36 mM HEBIB, 80 mM Asc, 170 M 
SDS and pH 7. 
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As expected, raising the temperature of the reaction increased the rate of turbidity formation. For the 
non-catalyzed and catalyzed reactions, E/t increased by a factor of 2.5 ± 0.6 for every 10 °C. 
Concerning the amplification time, increasing the temperature from 45 °C to 60 °C reduced the 
maximum amplification time from 20 ± 0.5 min to 6.3 ± 0.5 min. Measurements at 35  °C and 40 °C are 
close to the LCST of poly(NIPAAm), which is reported to be around 31-34 °C.44, 45, 63 To ensure an 
efficient precipitation, temperatures close to the LCST should be avoided. Using a temperature below 
60°C prevents possible hazards for the operator and reduces the energy consumption of the heating 
system. With these considerations, the operating temperature range should ideally be between 45 °C 
and 60 °C. Unless otherwise stated, we used 45 °C. 
pH is an important factor affecting the decomposition of ascorbate.47, 64, 65 Higher pH increases its 
decomposition into dehydro-L-ascorbic acid. The disproportionation of the monodehydroascorbate 
radical anion (Asc•-) is pH-dependent as well. Additionally, the ascorbate oxidation by oxygen can be 
highly promoted by the presence of metal traces such as iron or copper at neutral and basic pH.66 
Moreover, the pKa of hemozoin is around 7.55 Its exact value depends on the speciation of 
ferriprotoporphyrin IX which is influenced by the solvent composition. pH lower than 6 were not 
investigated because below this pH the solubility of hemozoin decreases leading to its precipitation 
and therefore a loss of catalytic activity.32, 67 In order to assess the pH-dependency of the precipitation 
polymerization assay, reactions were followed at pHs ranging from 6 to 8 at hemozoin concentrations 
of 0 and 100 ng mL-1 (Fig. 9). Reactions that were carried out at pH 8 were too fast to be followed with 
our experimental set-up, which requires a minute before measuring the extinction. 
 
Figure 9. Effect of pH on the rate of turbidity formation for precipitation polymerizations catalyzed by 
100 ng mL-1 sHz (red dot) and non-catalyzed reactions (blue triangle) (average of n = 3 and SD). The 
amplification time of the non-catalyzed reaction is displayed on the second y axis (grey square, average 
of n = 3 and SD). Reaction conditions: 800 mM NIPAAm, 36 mM HEBIB, 80 mM Asc, 170 M SDS and 
45 °C. 
The increase in pH had a considerable effect on precipitation kinetics, with an exponential increase in 
the rate of turbidity formation as a function of pH for both the catalyzed and the non-catalyzed 
reaction. The maximum amplification time greatly diminished from 59 ± 13 min down to 3.1 ± 0.5 min 
by raising the pH from 6 to 7.5. Importantly, increasing pH benefitted the catalyzed reaction more than 
the non-catalyzed reaction. This could be due to the increasing deprotonation of ferriprotoporphyrin 
IX with increasing pH. At pH 6, no difference between the catalyzed and non-catalyzed reaction was 
observed. This could be explained by catalyst precipitation, as its solubility decreases when reducing 
the pH.32, 67 The effect of pH on the non-catalyzed reaction might be explained by the influence of pH 
on the ascorbate species in solution. Fully protonated ascorbic acid (AscH2) is mainly found below pH 
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4.1, AscH- is found in majority up to pH 11.8, and at higher pH values Asc2- is dominant.47, 68 Asc2- is 
supposed to be the only compound capable of oxidizing in the absence of metal traces such as copper 
or iron.47 At lower pH, the concentration of Asc2- is lower. The reactivity of Asc with dissolved oxygen, 
which leads to the blank reaction, is therefore much slower at lower pH values.  
In conclusion, pH is an essential parameter that influences the catalyzed and the non-catalyzed 
precipitation polymerizations and the overall amplification time. Because of the reaction speed, pH 7.5 
was used in further experiments. Having a maximum amplification time of 3.1 ± 0.5 min is a great 
advantage towards a rapid diagnostic test. Moreover, these experiments clearly demonstrate that the 
pH must be precisely controlled by appropriate buffers to ensure the robustness of the test. Otherwise, 
a small increase in pH will result in a significant change of E/t.  
Assessment of the assay performance 
As elaborated above, the addition of 650 mM pyruvate and 170 M SDS improved the difference in 
the rate of turbidity formation between catalyzed and non-catalyzed reactions significantly, which 
facilitates the assignment of a sample as a hemozoin-containing sample or as a control or negative. In 
addition, increasing the pH to 7.5 greatly reduced the maximum amplification time. In order to 
determine the collective effect of these improvements, the dose response curve of the assay was 
measured between 0 and 4 ng mL-1 Hz using 650 mM pyruvate, 170  M SDS and 0.1 mM sodium 
phosphate buffer (pH 7.5, 10 % EtOH) (Fig. 10). 
 
Figure 10. Dose-response curve of the optimized hemozoin-catalyzed precipitation polymerization 
assay at low concentrations of synthetic hemozoin (average of n = 5 and SD, linear data fit (black line), 
95 % confidence interval (orange dotted line), decision limit (green vertical line) and limit of detection 
(red vertical line)). Maximum amplification time, i.e. the time of the non-catalyzed reaction is displayed 
on the second y axis (grey square, average of n = 5 and SD). Reaction conditions were 800 mM NIPAAm, 
36 mM HEBIB, 80 mM Asc, 650 mM Pyr, 170 M SDS, 45 °C and pH 7.5. 
The limit of detection (LOD) of the assay in the presence of SDS, pyruvate, and at pH 7.5 was 1.06 ng 
mL-1 with a confidence level of 95 %. The limit of decision was 0.62 ng mL-1. The previous generation 
of the assay had a LOD of 0.85 ng mL-1 and a decision limit of 0.49 ng mL-1 natural hemozoin without 
the use of SDS and pyruvate.28 Thus, the sensitivity of the assay did not change substantially with the 
change in reaction parameters.  The most important improvement of assay performance is, however, 
the amplification time. The assay was completed within 3 ± 0.5 min. This is significantly shorter than 
the time needed for the assay under the originally published assay conditions where the amplification 
time was 37 ± 5 min.28 A practically viable diagnostic assay should take 20 min or less.7 Thus, the 
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amplification time is now within that range and leaves time that can be dedicated to the sample 
preparation, i.e. the extraction of hemozoin from an infected blood sample.  
It is interesting to note that despite the improvements made to the speed of the test, the sensitivity 
did not increase. The major factor is that the change in reaction parameters did not only increase the 
rate of the catalyzed precipitation polymerization, but also the rate of the blank reaction. Nevertheless, 
the detection limit of the assay is very high and within a range that is relevant for the detection of low 
parasitemia patients.28 Classically, LOD is described in terms of infected red blood cells per L (iRBCs 
µL-1), but the translation from a hemozoin concentration to a parasitemia in iRBCs µL-1 is not so 
straightforward. The hemozoin concentration varies according to the life cycle of the parasite and its 
species. From the literature, it is possible to obtain a raw estimation of parasitemia from hemozoin 
concentration.28, 70, 71 As discussed in our previous report, a concentration of 0.85 ng mL-1 would 
correspond to a parasitemia of 1.4 iRBCs µL-1.28 Thus, an LOD of 1.06 ng mL-1 would correspond to a 
parasitemia in the range of 1 to 10 iRBCs µL-1, which is around 20 times better than the current malaria 
rapid diagnostic tests (MRDTs) and more than 5 times more sensitive than microscopy.72  
  
Conclusion 
In conclusion, the chemistry of the hemozoin-catalyzed precipitation polymerization assay is complex. 
The reagents ascorbate and HEBIB, as well as dissolved oxygen cause secondary reactions that lead to 
NIPAAm polymerization and, therefore, turbidity formation even in the absence of the catalyst. 
However, each of the reagents is essential for the proper functioning of the assay, and oxygen cannot 
be excluded because of practical reasons. The catalyzed and the non-catalyzed reactions, although 
complex, are reproducible and allow for a robust and highly sensitive assay. The addition of pyruvate 
considerably increased the catalytic activity of dissolved hemozoin, and the use of the surfactant SDS 
significantly improved the differentiation between catalyzed and non-catalyzed reaction. pH strongly 
influences the assay, with more basic conditions accelerating the reactions. Thus, control of pH is 
essential for the proper functioning of the test, especially at neutral to basic pHs where a small change 
in pH can lead to a significant change in the rate of turbidity formation. The use of 170 M SDS, 650 
mM pyruvate, and pH set to 7.5 have made it possible to reduce the amplification time to 3 ± 0.5 min 
while maintaining a low detection limit for synthetic hemozoin of 1.06 ng mL-1. The short amplification 
time is very important for the practical implementation of the assay in malaria diagnostics. Ultra-
sensitive malaria diagnostic methods, such as PCR, require hours.72 Fast diagnostics such as malaria 
rapid diagnostic immunotests are not sensitive enough to detect low levels of parasitemia in non-
symptomatic humans.72 In contrast, the optimized precipitation polymerization assay for hemozoin is 
both rapid and highly sensitive. A malaria test based on hemozoin-catalyzed polymerizations will 
consist of several steps that include blood sample collection, the extraction of hemozoin from blood, 
and the precipitation polymerization assay for hemozoin. As demonstrated earlier, natural hemozoin 
can be extracted from parasite-containing blood samples.28 However, also this step needs to be 
simplified and accelerated. Ongoing research in our laboratories aims to develop a simple and rapid 
extraction method of hemozoin from blood samples that provides good isolation efficiency and 
specificity for hemozoin, e.g. by the use of paper-based microfluidics. Finally, the chemical assay and 
a suitable extraction method need to be implemented into a diagnostic device, which will then have 
to be validated in field studies to assess its sensitivity and specificity as a point-of-care test in low 
resource settings.  
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